Literature DB >> 10968793

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

A S Neish1, A T Gewirtz, H Zeng, A N Young, M E Hobert, V Karmali, A S Rao, J L Madara.   

Abstract

Epithelia of the vertebrate intestinal tract characteristically maintain an inflammatory hyporesponsiveness toward the lumenal prokaryotic microflora. We report the identification of enteric organisms (nonvirulent Salmonella strains) whose direct interaction with model human epithelia attenuate synthesis of inflammatory effector molecules elicited by diverse proinflammatory stimuli. This immunosuppressive effect involves inhibition of the inhibitor kappaB/nuclear factor kappaB (IkappaB/NF-kappaB) pathway by blockade of IkappaB-alpha degradation, which prevents subsequent nuclear translocation of active NF-kappaB dimer. Although phosphorylation of IkappaB-alpha occurs, subsequent polyubiquitination necessary for regulated IkappaB-alpha degradation is completely abrogated. These data suggest that prokaryotic determinants could be responsible for the unique tolerance of the gastrointestinal mucosa to proinflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968793     DOI: 10.1126/science.289.5484.1560

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  217 in total

1.  NF-kappa B may determine whether epithelial cell--microbial interactions in the intestine are hostile or friendly.

Authors:  Y R Mahida; S Johal
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells.

Authors:  F Sierro; B Dubois; A Coste; D Kaiserlian; J P Kraehenbuhl; J C Sirard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 3.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 4.  Oral tolerance and gut-oriented immune response to dietary proteins.

Authors:  O Alpan
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 5.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 6.  Interaction of bacteria and bacterial toxins with intestinal epithelial cells.

Authors:  A Nusrat; S V Sitaraman; A Neish
Journal:  Curr Gastroenterol Rep       Date:  2001-10

Review 7.  Genomics at work: the global gene response to enteric bacteria.

Authors:  D Kelly; S Conway
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 8.  Probiotics in the management and prevention of atopy.

Authors:  John Bienenstock; Ryan E Wiley; G Scott Neigh; Susan Waserman; Paul Keith
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

Review 9.  Probiotics for infectious diarrhoea.

Authors:  E Isolauri
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 10.  NF-kappaB, a pivotal transcription factor in silica-induced diseases.

Authors:  Fei Chen; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.